Literature DB >> 23397822

Recurrent symptoms after stapled haemorrhoidopexy and the impact on patient satisfaction after a minimum of 2 years follow-up.

A M Wolthuis1, F Penninckx, J B Cornille, S Fieuws, A D'Hoore.   

Abstract

BACKGROUND: Stapled haemorrhoidopexy came as an attractive alternative to treat grade 3 haemorrhoids. This study aims to assess the nature of recurrent symptoms and the impact on patient satisfaction after a minimum follow-up of two years in a group of patients who underwent stapled haemorrhoidopexy.
METHODS: A standardized questionnaire was used to evaluate a consecutive group of patients by telephone treated by a stapled haemorrhoidopexy between January 2004 and December 2007. Outcome assessment comprised residual symptoms, subsequent treatment, and patient satisfaction.
RESULTS: Hundred sixty-five patients underwent a stapled haemorrhoidopexy in the study period. Twenty-five patients (15%) were lost to follow-up. The included 140 patients presented with grade 2 (16) or grade 3 (124) prolapsing internal haemorrhoids. Median age was 50 years (range 27-79) and 56% were males. Median follow-up was 43 months (range 25-87). At final follow-up, 79 patients (56%) remained symptom-free. Nevertheless, 89% were more than satisfied. Only 11% were disappointed with the ultimate outcome. Recurrent symptoms were prolapse (52 patients), anal bleeding (46 patients), anal pressure or pain (24 patients) and pruritus (21 patients). Thirty-five patients had subsequent therapy: 20 underwent surgical resection and 15 had sclerotherapy or rubber band ligation. Patient satisfaction correlates with the number of recurrent (residual) symptoms and the need for further treatment.
CONCLUSION: Despite the high symptomatic recurrence rate after stapled haemorrhoidopexy, 89% of patients were satisfied. This suggests that recurrent or residual symptoms after stapled haemorrhoidopexy are often less severe compared to the initial presenting symptoms.

Entities:  

Mesh:

Year:  2012        PMID: 23397822     DOI: 10.1080/00015458.2012.11680865

Source DB:  PubMed          Journal:  Acta Chir Belg        ISSN: 0001-5458            Impact factor:   1.090


  2 in total

1.  Comparing the effect of An's Shaobei Injection ([symbols; see text]) with Xiaozhiling Injection ([symbols; see text]) in patients with internal hemorrhoids of grade I-III: a prospective cohort study.

Authors:  A-yue An; Da-yong Feng; Chun-hui Wang; Yu-ying Shi; Jing-jing Xiang; Zhi-yong Bai; Kun-cheng Li; Jin-yang Liu
Journal:  Chin J Integr Med       Date:  2014-06-28       Impact factor: 1.978

2.  Myofibrotic malformation vessels: unique angiodysplasia toward the progression of hemorrhoidal disease.

Authors:  Sheng-Long Li; Fang-Yan Jing; Li-Li Ma; Li-Li Guo; Feng Na; Sheng-Li An; Yan Ye; Jun-Ming Yang; Ming Bao; Dong Kang; Xiao-Lan Sun; Yong-Jian Deng
Journal:  Drug Des Devel Ther       Date:  2015-08-13       Impact factor: 4.162

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.